1	Monoclonal	monoclonal	_	_	_	_	_	_	_
2	anti-endothelial	anti-endothelial	_	_	_	_	_	_	_
3	cell	cell	_	_	_	_	_	_	_
4	antibodies	antibody	_	_	_	_	_	_	_
5	from	from	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	patient	patient	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	Takayasu	Takayasu	_	_	_	_	_	_	_
10	arteritis	arteritis	_	_	_	_	_	_	_
11	activate	activate	_	_	_	_	_	_	_
12	endothelial	endothelial	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	from	from	_	_	_	_	_	_	_
15	large	large	_	_	_	_	_	_	_
16	vessels	vessel	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	OBJECTIVE	objective	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	To	to	_	_	_	_	_	_	_
4	create	create	_	_	_	_	_	_	_
5	monoclonal	monoclonal	_	_	_	_	_	_	_
6	anti-endothelial	anti-endothelial	_	_	_	_	_	_	_
7	cell	cell	_	_	_	_	_	_	_
8	antibodies	antibody	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	mAECA	mAECA	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	from	from	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	patient	patient	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	Takayasu	Takayasu	_	_	_	_	_	_	_
17	arteritis	arteritis	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	evaluate	evaluate	_	_	_	_	_	_	_
20	their	their	_	_	_	_	_	_	_
21	ability	ability	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	activate	activate	_	_	_	_	_	_	_
24	human	human	_	_	_	_	_	_	_
25	umbilical	umbilical	_	_	_	_	_	_	_
26	vein	vein	_	_	_	_	_	_	_
27	endothelial	endothelial	_	_	_	_	_	_	_
28	cells	cell	_	_	_	_	_	_	_
29	(	(	_	_	_	_	_	_	_
30	HUVEC	HUVEC	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	to	to	_	_	_	_	_	_	_
35	characterize	characterize	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	mechanism	mechanism	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	EC	EC	_	_	_	_	_	_	_
40	activation	activation	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	A	a	_	_	_	_	_	_	_
4	panel	panel	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	mAECA	mAECA	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	generated	generate	_	_	_	_	_	_	_
9	from	from	_	_	_	_	_	_	_
10	peripheral	peripheral	_	_	_	_	_	_	_
11	blood	blood	_	_	_	_	_	_	_
12	lymphocytes	lymphocyte	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	patient	patient	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	Takayasu	Takayasu	_	_	_	_	_	_	_
18	arteritis	arteritis	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	using	use	_	_	_	_	_	_	_
21	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
22	virus	virus	_	_	_	_	_	_	_
23	transformation	transformation	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Activity	activity	_	_	_	_	_	_	_
2	against	against	_	_	_	_	_	_	_
3	macrovascular	macrovascular	_	_	_	_	_	_	_
4	EC	EC	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	HUVEC	HUVEC	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	microvascular	microvascular	_	_	_	_	_	_	_
10	EC	EC	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	human	human	_	_	_	_	_	_	_
13	bone	bone	_	_	_	_	_	_	_
14	marrow	marrow	_	_	_	_	_	_	_
15	EC	EC	_	_	_	_	_	_	_
16	immortalized	immortalize	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	SV40	SV40	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	antigens	antigen	_	_	_	_	_	_	_
21	was	be	_	_	_	_	_	_	_
22	detected	detect	_	_	_	_	_	_	_
23	by	by	_	_	_	_	_	_	_
24	enzyme-linked	enzyme-linked	_	_	_	_	_	_	_
25	immunosorbent	immunosorbent	_	_	_	_	_	_	_
26	assay	assay	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	used	use	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	select	select	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	monoclonal	monoclonal	_	_	_	_	_	_	_
9	antibodies	antibody	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	mAECA	mAECA	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	which	which	_	_	_	_	_	_	_
14	share	share	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	same	same	_	_	_	_	_	_	_
17	EC	EC	_	_	_	_	_	_	_
18	epitope	epitope	_	_	_	_	_	_	_
19	binding	binding	_	_	_	_	_	_	_
20	specificity	specificity	_	_	_	_	_	_	_
21	as	as	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	total	total	_	_	_	_	_	_	_
24	IgG-AECA	igg-aeca	_	_	_	_	_	_	_
25	from	from	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	Takayasu	Takayasu	_	_	_	_	_	_	_
28	arteritis	arteritis	_	_	_	_	_	_	_
29	patient	patient	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	binding	binding	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	mAECA	maeca	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	aortic	aortic	_	_	_	_	_	_	_
9	EC	EC	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	studied	study	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	immunohistochemistry	immunohistochemistry	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	secretion	secretion	_	_	_	_	_	_	_
3	levels	level	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	interleukin-6	interleukin-6	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	IL-6	il-6	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	von	von	_	_	_	_	_	_	_
11	Willebrand	Willebrand	_	_	_	_	_	_	_
12	factor	factor	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	vWF	vWF	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	were	be	_	_	_	_	_	_	_
17	determined	determine	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	serve	serve	_	_	_	_	_	_	_
21	as	as	_	_	_	_	_	_	_
22	markers	marker	_	_	_	_	_	_	_
23	for	for	_	_	_	_	_	_	_
24	EC	EC	_	_	_	_	_	_	_
25	activation	activation	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	activated	activate	_	_	_	_	_	_	_
3	EC	EC	_	_	_	_	_	_	_
4	were	be	_	_	_	_	_	_	_
5	examined	examine	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	adherence	adherence	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	monocytic	monocytic	_	_	_	_	_	_	_
12	cell	cell	_	_	_	_	_	_	_
13	line	line	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	U937	U937	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	as	as	_	_	_	_	_	_	_
19	well	well	_	_	_	_	_	_	_
20	as	as	_	_	_	_	_	_	_
21	for	for	_	_	_	_	_	_	_
22	expression	expression	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	vascular	vascular	_	_	_	_	_	_	_
25	cell	cell	_	_	_	_	_	_	_
26	adhesion	adhesion	_	_	_	_	_	_	_
27	molecule	molecule	_	_	_	_	_	_	_
28	1	1	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	intercellular	intercellular	_	_	_	_	_	_	_
31	adhesion	adhesion	_	_	_	_	_	_	_
32	molecule	molecule	_	_	_	_	_	_	_
33	1	1	_	_	_	_	_	_	_
34	,	,	_	_	_	_	_	_	_
35	and	and	_	_	_	_	_	_	_
36	E-selectin	E-selectin	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	extracts	extract	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	mAECA-treated	maeca-treated	_	_	_	_	_	_	_
9	EC	EC	_	_	_	_	_	_	_
10	were	be	_	_	_	_	_	_	_
11	analyzed	analyze	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	induction	induction	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	translocation	translocation	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	nuclear	nuclear	_	_	_	_	_	_	_
19	factor	factor	_	_	_	_	_	_	_
20	kappaB	kappaB	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	using	use	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	specific	specific	_	_	_	_	_	_	_
28	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
29	oligoprobe	oligoprobe	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	an	an	_	_	_	_	_	_	_
32	electrophoretic	electrophoretic	_	_	_	_	_	_	_
33	mobility	mobility	_	_	_	_	_	_	_
34	shift	shift	_	_	_	_	_	_	_
35	assay	assay	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	RESULTS	results	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Six	six	_	_	_	_	_	_	_
4	mAECA	maeca	_	_	_	_	_	_	_
5	were	be	_	_	_	_	_	_	_
6	selected	select	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	mixture	mixture	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	which	which	_	_	_	_	_	_	_
12	produced	produce	_	_	_	_	_	_	_
13	100	100	_	_	_	_	_	_	_
14	%	%	_	_	_	_	_	_	_
15	inhibition	inhibition	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	binding	binding	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	original	original	_	_	_	_	_	_	_
21	IgG	igg	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	from	from	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	patient	patient	_	_	_	_	_	_	_
26	with	with	_	_	_	_	_	_	_
27	Takayasu	Takayasu	_	_	_	_	_	_	_
28	arteritis	arteritis	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	to	to	_	_	_	_	_	_	_
31	HUVEC	HUVEC	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	All	all	_	_	_	_	_	_	_
2	mAECA	mAECA	_	_	_	_	_	_	_
3	possessed	possess	_	_	_	_	_	_	_
4	high	high	_	_	_	_	_	_	_
5	activity	activity	_	_	_	_	_	_	_
6	against	against	_	_	_	_	_	_	_
7	macrovascular	macrovascular	_	_	_	_	_	_	_
8	EC	EC	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	but	but	_	_	_	_	_	_	_
11	none	none	_	_	_	_	_	_	_
12	had	have	_	_	_	_	_	_	_
13	significant	significant	_	_	_	_	_	_	_
14	antimicrovascular	antimicrovascular	_	_	_	_	_	_	_
15	EC	EC	_	_	_	_	_	_	_
16	activity	activity	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	mAECA	maeca	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	but	but	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	normal	normal	_	_	_	_	_	_	_
7	human	human	_	_	_	_	_	_	_
8	IgG	igg	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	had	have	_	_	_	_	_	_	_
11	anti-human	anti-human	_	_	_	_	_	_	_
12	aortic	aortic	_	_	_	_	_	_	_
13	EC	EC	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Four	four	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	6	6	_	_	_	_	_	_	_
5	mAECA	maeca	_	_	_	_	_	_	_
6	activated	activate	_	_	_	_	_	_	_
7	EC	EC	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	manifested	manifest	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	increased	increase	_	_	_	_	_	_	_
12	IL-6	il-6	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	vWF	vwf	_	_	_	_	_	_	_
15	secretion	secretion	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	4	4	_	_	_	_	_	_	_
3	mAECA	maeca	_	_	_	_	_	_	_
4	induced	induce	_	_	_	_	_	_	_
5	EC	EC	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	adhesion	adhesion	_	_	_	_	_	_	_
9	molecules	molecule	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	increased	increase	_	_	_	_	_	_	_
12	adhesion	adhesion	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	U937	u937	_	_	_	_	_	_	_
15	monocytic	monocytic	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	EC	EC	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	these	these	_	_	_	_	_	_	_
5	mAECA	maeca	_	_	_	_	_	_	_
6	stimulated	stimulate	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	nuclear	nuclear	_	_	_	_	_	_	_
9	translocation	translocation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
13	transcription	transcription	_	_	_	_	_	_	_
14	factor	factor	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	CONCLUSION	conclusion	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Our	our	_	_	_	_	_	_	_
4	findings	finding	_	_	_	_	_	_	_
5	suggest	suggest	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	AECA	AECA	_	_	_	_	_	_	_
8	may	may	_	_	_	_	_	_	_
9	directly	directly	_	_	_	_	_	_	_
10	stimulate	stimulate	_	_	_	_	_	_	_
11	EC	EC	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	Takayasu	Takayasu	_	_	_	_	_	_	_
14	arteritis	arteritis	_	_	_	_	_	_	_
15	through	through	_	_	_	_	_	_	_
16	elevation	elevation	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	adhesion	adhesion	_	_	_	_	_	_	_
19	molecule	molecule	_	_	_	_	_	_	_
20	expression	expression	_	_	_	_	_	_	_
21	associated	associate	_	_	_	_	_	_	_
22	with	with	_	_	_	_	_	_	_
23	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
24	activation	activation	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	adhesion	adhesion	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	monocytes	monocyte	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	may	may	_	_	_	_	_	_	_
32	therefore	therefore	_	_	_	_	_	_	_
33	play	play	_	_	_	_	_	_	_
34	a	a	_	_	_	_	_	_	_
35	pathogenic	pathogenic	_	_	_	_	_	_	_
36	role	role	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	development	development	_	_	_	_	_	_	_
40	of	of	_	_	_	_	_	_	_
41	the	the	_	_	_	_	_	_	_
42	vasculopathy	vasculopathy	_	_	_	_	_	_	_
43	in	in	_	_	_	_	_	_	_
44	Takayasu	Takayasu	_	_	_	_	_	_	_
45	arteritis	arteritis	_	_	_	_	_	_	_
46	.	.	_	_	_	_	_	_	_

